Press release
Enovate Biolife enters the Filipino Supplement Market
Enovate Biolife signed a collaboration agreement with Manila-based MP-AIMM Marketing Corporation to enter the Philippines Supplements Market.For Immediate Release
Redwood City, CA, June 15, 2011: The research products of Enovate Biolife will be now available in Philippines through the distribution channel of MP-AIMM Marketing Corporation. The company has tied-up with AIMM, marketing various products and services with distribution networks all over the country.
“We are pleased to partner with AIMM, the leading & established company of Philippines in a niche segment. Their innovations and expertise in distribution network coupled with our researched and proven products will certainly yield the best business results for both the companies”, said Jayesh Chaudhary, President, Enovate Biolife
MP-AIMM is a private company dealing mainly with healthcare products; bio-fertilizers, pesticides and a diverse range of services. Their crop protection products are available in Australia, Europe, China, Thailand and soon in Korea.
ENovate Biolife is a Specialty Healthcare Company in Design and Development of Scientifically validated Dietary Supplements and Medical Foods. ENovate is part of a Multinational group with presence in US and Asia, having 2 decades of experience in the Healthcare industry.
ENOVATE BIOLIFE
URL: www.enovatebiolife.com
Email: bizdev2@enovatebiolife.com
ENovate Biolife is a Specialty Healthcare Company in Design and Development of Scientifically validated Dietary Supplements and Medical Foods. ENovate is part of a Multinational group with presence in US and Asia, having 2 decades of experience in the Healthcare industry.
203, Morya Landmark, Off New Link Road, Andheri(w), Mumbai-400053
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Enovate Biolife enters the Filipino Supplement Market here
News-ID: 185904 • Views: …
More Releases from enovatebiolife
ENovate Biolife Targets African Market
Salt Lake City, Utah (Sept 10, 2011) – ENovate Biolife LLC is pleased to announce their participation at Medexpo Kenya 2011 at Nairobi. The Medexpo Kenya will take place on 17-19 September 2011 at Sarit Centre. Medexpo Kenya is the prime event in the region attracting visitors from all over East & Central Africa displaying vast range of products from Hospital Supplies, Medical Equipment, Dental Equipment, Healthcare supplements and Pharmaceuticals.…
ENovate Biolife announces start of Clinical Study for Rhinitis
For Immediate Release
California, July 20, 2011: ENovate Biolife, a specialty healthcare company, announced today that it has initiated a Phase IIa clinical trial with its lead product E-RH-06 in subjects with Rhinitis. ENovate Biolife has received ethics committee approval for safety and dose determining study for investigational product E-RH-06 for the metabolic management of chronic or recurrent, non-infective nasal congestion with-or-without rhinorrhea.
Rhinitis (allergic or non allergic) is a clinical problem…
ENovate Biolife Targets Asia-Pacific Markets
Salt Lake City, Utah (July 20, 2011) – ENovate Biolife LLC is pleased to announce their participation at Natural Products Expo Asia 2011 in Hong Kong. The 9th Natural Products Expo Asia (www.naturalproductsasia.com) will take place at the Hong Kong Convention and Exhibition Centre on 25 – 27 August 2011. It is the premier sourcing trade show for Asia’s natural, organic and healthy products industry, attracting over 350 exhibitors and…
Joint Health Supplement
Salt Lake City, Utah (July 19, 2011) – ENovate Biolife LLC, announced the launch of its clinically documented supplement for joint health ‘Lanconone’. Lanconone is popular worldwide and is now available online in the US. Lanconone is an all natural formula tested to deliver greater joint flexibility and facilitate walking, bending, climbing, gardening and other everyday activities. Lanconone is manufactured under Gold standards using standardized ingredients to give fast and…
More Releases for Biolife
Global Organ preservation Market 2020 Business Strategies – BioLife SolutionsI …
The market report titled “Organ preservation Market By Technique (Static Cold Storage, Hypothermic Perfusion Preservation And Other Techniques), By Preservation Solution (Viaspan, Custodiol HTK, Renograf, Perfadex, Human Biosystem (HBS) Solution, Lifor and Others) For Kidney, Lung, Liver, Heart And Other Organs: Global Industry Perspective, Comprehensive Analysis and Forecast, 2016-2022” and published by Zion Market Research will put forth a systematizedevaluation of the vital facets of the global Organ preservation Market…
Global Organ preservation Market 2020 Business Strategies – BioLife SolutionsI …
The Zion Market Research added a new report “Organ preservation Market By Technique (Static Cold Storage, Hypothermic Perfusion Preservation And Other Techniques), By Preservation Solution (Viaspan, Custodiol HTK, Renograf, Perfadex, Human Biosystem (HBS) Solution, Lifor and Others) For Kidney, Lung, Liver, Heart And Other Organs: Global Industry Perspective, Comprehensive Analysis and Forecast, 2016-2022” in its database, which provides an expert and in-depth analysis of key business trends and future market…
Global Biobanking Market: Top Manufacturers - DNA Genotek, Micronic, Askion, Bio …
Latest industry research report on: Global Biobanking Market : Industry Size, Share, Research, Reviews, Analysis, Strategies, Demand, Growth, Segmentation, Parameters, Forecasts
Complete Report Details @ http://www.marketresearchreports.biz/analysis/957792
This report studies Global Biobanking market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with capacity, production, price, revenue and market share for each manufacturer, covering
Beckman Coulter
Thermo Fisher
…
ENovate Biolife reports encouraging results for their Rhinitis Product
ENovate Biolife, a specialty healthcare company, announced new data showing how the company’s lead investigational product E-RH-06 will work for the metabolic management of chronic or recurrent, non-infective nasal congestion with-or-without rhinorrhea.
Acute or chronic inflammation of nasal mucous membrane is a hallmark of rhinitis, which may be caused by viruses, bacteria or irritants. The inflammation results in the generation of excessive amounts of mucus, nasal congestion, sneezing and itchiness…
ENovate Biolife Targets African Market
Salt Lake City, Utah (Sept 10, 2011) – ENovate Biolife LLC is pleased to announce their participation at Medexpo Kenya 2011 at Nairobi. The Medexpo Kenya will take place on 17-19 September 2011 at Sarit Centre. Medexpo Kenya is the prime event in the region attracting visitors from all over East & Central Africa displaying vast range of products from Hospital Supplies, Medical Equipment, Dental Equipment, Healthcare supplements and Pharmaceuticals.…
ENovate Biolife announces start of Clinical Study for Rhinitis
For Immediate Release
California, July 20, 2011: ENovate Biolife, a specialty healthcare company, announced today that it has initiated a Phase IIa clinical trial with its lead product E-RH-06 in subjects with Rhinitis. ENovate Biolife has received ethics committee approval for safety and dose determining study for investigational product E-RH-06 for the metabolic management of chronic or recurrent, non-infective nasal congestion with-or-without rhinorrhea.
Rhinitis (allergic or non allergic) is a clinical problem…
